The evils of nicotine: an evidence-based guide to smoking and plastic surgery.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 23542839.
- Also identified by DOI 10.1097/SAP.0b013e3182764fcd.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
As nearly 1 of 5 adult Americans are smokers, plastic surgeons should be familiar with the effect of smoking on perioperative risk, the importance of smoking cessation, and the tools to help patients quit. Cigarette smoke contains over 250 known toxins, including nicotine, carbon monoxide, hydrogen cyanide, and nitric oxide, which all are known to impair wound healing, through multiple mechanisms. The relationship of smoking and delayed postoperative wound healing has been established in numerous prospective and retrospective cohort studies (level 2 and 3 evidence), and has been demonstrated across a wide range of surgical disciplines and procedures, including many common plastic surgical procedures. The ameliorating effects of cessation are supported by level 1 evidence, which suggests that the optimal duration of preoperative cessation is 4 weeks or longer. Nicotine replacement therapy and smoking cessation medications are effective aids for quitting and should be familiar to plastic surgeons.
Medical subject headings
- Cosmetic Techniques
- Postoperative Complications
- Preoperative Care
- Plastic Surgery Procedures
- Smoking
- Smoking Cessation